Epinephrine News and Research

RSS

High burden of multi-food allergies among children and adults in the U.S.

A new study in the journal Annals of Allergy, Asthma & Immunology aimed to characterize the characteristics, prevalence, determinants, distribution, and psychosocial burden of multi-FA among adults and children in the US.

3 Jan 2023

Study: Only half of food allergic adult patients have immediate access to epinephrine

Epinephrine is the only medication that can stop anaphylaxis and it is critical that everyone with a food allergy has access to epinephrine to treat life threatening reactions.

10 Nov 2022

Anaphylaxis symptoms in most infants appear to resolve with a single dose of epinephrine

Although many parents of infants worry about their child having a food allergy, there has not been a lot of research into the presentation of anaphylaxis in infants.

10 Nov 2022

Progress and challenges in the development of mRNA vaccines against respiratory syncytial virus

New research discussed the structure and life cycle of respiratory syncytial virus (RSV), the current research on the treatment and prevention of RSV infections, and the advancements in RSV mRNA vaccine technology after the surge in vaccine research during the COVID-19 pandemic.

1 Nov 2022

Smartphone code blue notification may accelerate response to in-hospital cardiac arrest

Sixty seconds can make or break the outcome of a hospital "code blue" or cardiac arrest response. New research found a hospital code response team rushing to a patient in cardiac arrest may arrive at least one minute quicker and may also lead to better patient outcomes with the use of a smartphone emergency code notification system that activates the team through text messages.

31 Oct 2022

Scientists reveal why cancers of the adrenal glands are more common among women

Why are cancers of the adrenal glands1 more common among women? Why are prognoses worse for them? A team of scientists led by a CNRS researcher answers these questions in an article published on 14 October 2022 in Science Advances.

14 Oct 2022

Availability of lower-priced epinephrine auto-injectors did not solve the affordability problem for all patients with severe allergies

People with severe allergies now have more choices for which epinephrine auto-injector to carry in case they suffer a life-threatening attack, and most pay less for it than they did when the EpiPen was the primary option, a new study shows.

12 Jul 2022

Study finds hospitalizations for COVID-19–related croup increased after the onset of the Omicron variant

Researchers assessed whether croup infections among young children in the United States were associated with the emergence of new SARS-CoV-2 variants of concern Omicron.

5 Jul 2022

Oral immunotherapy for peanut allergies is highly effective when started for infants under 12 months

UBC researchers demonstrated in 2019 that pre-schoolers can safely overcome peanut allergies with a treatment called oral immunotherapy.

16 Jun 2022

SARS-CoV-2 Omicron linked to rise in croup in young children

A recent Pediatrics study assesses the causative relationship between SARS-CoV-2 infection and croup or “barking cough” in children.

19 May 2022

Educational attainment associated with better health in Black women

One of the best things Black women can do for their health may be to get a college education, according to results of a national analysis.

3 May 2022

People with elevated blood pressure upon standing more likely to have risk for cardiovascular events

Among young and middle-aged adults with high blood pressure, a substantial rise in blood pressure upon standing may identify those with a higher risk of serious cardiovascular events, such as heart attack and stroke, according to new research published today in the American Heart Association's peer-reviewed journal Hypertension.

17 Mar 2022

Croup: A previously unrecognized complication of COVID-19 in young children

The omicron surge has led to a previously unrecognized complication of COVID-19 in young children: croup. In the first peer-reviewed report to date, physicians at Boston Children's Hospital describe 75 children who came to the hospital's emergency department (ED) with croup and COVID-19 from March 1, 2020 through January 15, 2022.

15 Mar 2022

Study provides new insights into the communication of bacteria with their host

A newly discovered protein helps bacteria recognize stress hormones in the human body and direct their motion in the host.

7 Mar 2022

Low risk of second allergic reaction after SARS-CoV-2 vaccination

In a recent investigation posted to the journal JAMA Internal Medicine,* researchers estimate the risk of a repeated allergic reaction to the second severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccine dose in those with a history of allergic responses following the first dose by conducting a systematic review and meta-analysis.

22 Feb 2022

Exploring the high incidence of croup in children during the SARS-CoV-2 Omicron wave

In a new study, researchers observed that the incidence of pediatric croup was higher during the latest surge of COVID-19 infections driven by the SARS-CoV-2 Omicron variant.

8 Feb 2022

New opportunity to induce remission of peanut allergy in young children through oral immunotherapy

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5 years.

21 Jan 2022

Study shows efficacy, safety of oral immunotherapy in one- to three-year-olds with peanut allergy

The majority of young children treated with peanut immunotherapy achieved desensitization after two and a half years of treatment, and one in five remained in remission 26 weeks after treatment ended, according to a randomized controlled trial published in The Lancet.

20 Jan 2022

Researchers identify a biomarker in platelets that tracks the extent of depression

Researchers are one step closer to developing a blood test that provides a simple biochemical hallmark for depression and reveals the efficacy of drug therapy in individual patients.

3 Jan 2022

Earlier epinephrine administration associated with better recovery after cardiac arrest

Earlier epinephrine treatment during a cardiac arrest is linked to better recovery compared to later treatment, according to preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium (ReSS) 2021.

8 Nov 2021